2019
DOI: 10.3389/fimmu.2019.00346
|View full text |Cite
|
Sign up to set email alerts
|

Neutrophil Heterogeneity as Therapeutic Opportunity in Immune-Mediated Disease

Abstract: Neutrophils are versatile innate effector cells essential for immune defense but also responsible for pathologic inflammation. This dual role complicates therapeutic targeting. However, neither neutrophils themselves nor the mechanisms they employ in different forms of immune responses are homogeneous, offering possibilities for selective intervention. Here we review heterogeneity within the neutrophil population as well as in the pathways mediating neutrophil recruitment to inflamed tissues with a view to out… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
95
0
5

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 104 publications
(103 citation statements)
references
References 193 publications
(233 reference statements)
3
95
0
5
Order By: Relevance
“…Previous studies, including those from our own group, have already suggested a role for neutrophils in autoimmunity ( 12 14 ) and highlight context-specific diversity in neutrophil identity, plasticity, and function ( 15 ). Neutrophil heterogeneity is now a recognized phenomenon associated closely with several diseases.…”
Section: Introductionmentioning
confidence: 70%
See 1 more Smart Citation
“…Previous studies, including those from our own group, have already suggested a role for neutrophils in autoimmunity ( 12 14 ) and highlight context-specific diversity in neutrophil identity, plasticity, and function ( 15 ). Neutrophil heterogeneity is now a recognized phenomenon associated closely with several diseases.…”
Section: Introductionmentioning
confidence: 70%
“…Neutrophil heterogeneity is now a recognized phenomenon associated closely with several diseases. However, evidence of unequivocal characterization of bona fide neutrophil subsets, particularly in the context of pathological conditions, has not yet been reported, to our knowledge ( 14 16 ).…”
Section: Introductionmentioning
confidence: 93%
“…Neutrophil heterogeneity can be phenotypic or functional and is pronounced at different levels of their life cycle, either in homeostatic or disease conditions (13,28). Infectious inflammation can induce rapid changes in neutrophil variants as a function of maturity or activation state (11,28). While the innate immune response is the initial responders to infection, the other cellular response are also important.…”
Section: Discussionmentioning
confidence: 99%
“…The ectodomain shedding of CD62L from neutrophil plasma membrane denotes neutrophil activation or partial activation (priming), concordant with upregulation of CD11b, a component of the macrophage-1 antigen (Mac-1) (CD11b/CD18) β 2 -integrin subfamily (9). Appearance of the surface marker, CD54, on activated neutrophils correlates with reverse transendothelial migration, and its expression is known to be increased by inflammatory stimuli (10,11). Neutrophils showing antitumorigenic phenotypes show increased CD54 expression (12), while CD54 expressing neutrophils are also associated with chronic systemic inflammation (13).…”
Section: Introductionmentioning
confidence: 88%
“…In vivo interference with the production of neutrophil extracellular traps (NETs) has been shown to be protective in systemic lupus erythematosus (SLE) (73) and transfusion-related acute lung injury (TRALI) (74), whereas the β1-adrenergic-receptor antagonist metoprolol decreases infarct size during AMI by interfering neutrophil recruitment and neutrophil-platelet interactions (75). These and other examples postulate the possibility to target neutrophils therapeutically, as reviewed recently (76,77). Given the observation that the molecular clock influences the effector functions of neutrophils, an outstanding question is whether this "neutrophil clock" can be targeted to prevent inflammatory disease.…”
Section: Targeting the Circadian Properties Of Neutrophils For Therapymentioning
confidence: 99%